Key Highlights:
- Zydus Lifesciences has launched PEPAIR, described as India’s first affordable oscillating positive expiratory pressure (OPEP) device designed to help clear airway congestion and improve breathing in patients with chronic respiratory conditions.
- Developed under an agreement with AeroDel Technology Innovations, the drug-free handheld device features a patented three-resistance system that creates pressure and vibrations during exhalation to loosen mucus and support airway clearance. It is intended for patients with Chronic Obstructive Pulmonary Disease, Asthma, and Bronchiectasis.
- Priced at INR 990 per unit, PEPAIR aims to improve access to OPEP therapy, which is recommended in clinical guidance but has remained costly for many patients. With respiratory diseases rising in India due to pollution, urbanisation, and delayed diagnosis, the launch expands Zydus’s respiratory portfolio alongside inhalation therapies and bronchodilator brands such as Deriphyllin.
Implications:
PEPAIR smashes cost barriers to OPEP therapy, handing pulmonologists a game-changing tool that slots perfectly alongside Zydus inhalers and Deriphyllin.
Tier-2 clinics finally access clinical gold standard mucus clearance, exploding daily use while imported rivals fade into premium obscurity.
Zydus cements respiratory portfolio dominance, capturing everyday care market as air quality crises multiply across urban India.
Source: Expresspharma | Image: Zydus
Other Articles
Next
Previous
No Comment! Be the first one.